This video showcases a neutralization assay measuring serum efficacy in neutralizing SARS-CoV-2 viruses. It involves pseudotyped viruses, serum dilution, and luminescence-based quantification, revealing the neutralization titer.
Protocol
All procedures involving sample collection have been performed in accordance with the institute's IRB guidelines. 1. Pseudotype-based neutralization assay NOTE: pMN is the Inhibition of pseudotype virus (PV) mediated transduction via human convalescent serum samples that contain antibodies directed against the SARS-CoV-2 Spike. In a 96-well white plate with the aid of a multichannel pipette, add 50 µl …
Coronavirus Spike (S) protein priming transmembrane serine protease 2 (TMPRSS2) expression plasmid: pCAGGS-TMPRSS2
Bertram 2010
Dulbecco's modified Eagle medium (DMEM) with 4.5 g/L Glucose, supplemented with 10% foetal bovine serum (FBS) and 1% penicillin/streptomycin (P/S)
Pan-Biotech
P04-04510
P40-37500
P06-07100
FuGENE® HD Transfection Reagent, 1ml
Promega
E2311
Trypsin-EDTA (0.05%), phenol red
Pan-Biotech
P10-040100
Positive control antibody (Research Reagent for Anti-SARS-CoV-2 Ab) that can neutralise the SARS-CoV-2 PV (NIBSC, code: 20/162, available internationally or HICC-pool 2/HICC pool 3)